Status:
COMPLETED
Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS)
Lead Sponsor:
University of Copenhagen
Collaborating Sponsors:
Glostrup University Hospital, Copenhagen
Rigshospitalet, Denmark
Conditions:
Schizophrenia
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
The investigators want to relate disturbances in first-episode schizophrenic patients in (dopaminergic) D2 receptors, brain structure, brain function, and information processing to each other and to p...
Detailed Description
The study is designed as a 6 week case-control follow-up study of 70 AN FE pt. with SCZ and 70 controls matched with regard to age, gender, and parental socio-economic status. All subjects will be exa...
Eligibility Criteria
Inclusion
- For patients: meeting diagnostic criteria for schizophrenia according to ICD 10 or DSM IV antipsychotic naive The controls will be matched to the patients according to gender age and parental socio-economic status.
- \-
Exclusion
- Patients: mental retardation, other chronic diseases, use of antidepressive medicine during the last month,being pregnant, on going substance abuse
- Controls: psychiatric diagnosis, psychiatric diagnosis in first-degree relatives,on going drug abuse, mental retardation -
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT01154829
Start Date
December 1 2008
End Date
May 1 2016
Last Update
May 26 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Neuropsychiatric Schizophrenia Research, University of Copenhagen, Psychiatric Center Glostrup
Glostrup Municipality, Denmark, DK-2600